IRCT2015080423478N1已完成未知
Celecoxib versus placebo as an adjunct in the treatment of Adolescents with bipolar mood disorder: a double blind randomized, placebo controlled study.
Vice chancellor for research, Tehran University of Medical Sciences, DR Masud Younesian0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 18 years（—）
- 性别
- All
入选标准
- •Bipolar disorder (first episode); acute illness episode; manic phase; and Young Mania Rating Scale score 20 or more; age 12 to 18 years
- •Exclusion criteria: Liver, kidney, heart and thyroid disorders at present; history of renal dysfunction or heart or a history of stomach ulcers; hypersensitivity to sulfonamides; co-morbidity risk of autism spectrum disorders; the risk of mental retardation; substance abuse over the past year; Mood Disorder caused by physical illness such as seizures; head trauma and other diseases
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Efficacy of celecoxib in the treatment of bipolar disorderIRCT201307171556N53Tehran University of Medical Sciences50
已完成
不适用
evaluation of adding celecoxib to treatment of mood disorder patients receiving electroconvulsive therapymood disorde.bipolar affective disorder/ depressive disorderF30-F39IRCT201201247202N2Tehran University of Medical Sciences50
招募中
3 期
The effect of Celecoxib in the treatment of SchizophreniaSchizophreniaIRCT20210831052351N1niversity of social welfare and rehabilitation sciences52
招募中
Unknown
Evaluating the effect of celecoxib in comparison with acetaminophen on orthodontic pain managementIRCT20221109056454N1Tehran University of Medical Sciences70
招募中
3 期
Effects of add-on Celecoxib treatment in patients with schizophrenia spectrum disorders and inflammatory cytokine profile (TargetFlame)Schizophrenie oder schizophrene Spektrum-erkrankungF20SchizophreniaDRKS00029044Bezirkskliniken Schwaben109